Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol USP9X contributors: mct - updated : 05-09-2019
HGNC name ubiquitin specific peptidase 9, X-linked
HGNC id 12632
EXPRESSION
Type ubiquitous
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Endocrineneuroendocrinepituitary  highly
Reproductivefemale systemuteruscervix highly
Respiratorylung   highly
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period embryo, pregnancy
Text embryo, at low levels
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • five highly conserved domains, domains I, II and III containing the expected catalytic triad Cys, Asp, His which defines cysteine proteases
  • catalytic and ubiquitin-like domains
  • C terminus of USP9X binds the regulator of neuronal cell migration Doublecortin
  • HOMOLOGY
    interspecies homolog to murine Dres14
    homolog to Drosophila developmental gene fat facets related on the X
    Homologene
    FAMILY
  • deubiquitin family
  • peptidase C19 family
  • CATEGORY enzyme , tumor suppressor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,cytosolic
    intracellular,cytoplasm,cytoskeleton,microtubule
    intracellular,nucleus,nucleoplasm
    text
  • interacting with MARCH7 in the cytosol
  • mostly cytosolic, but is also found in the nucleoplasm
  • localizes along the length of the ciliary axoneme
  • basic FUNCTION
  • may function as a ubiquitin-protein or polyubiquitin hydrolase involved both in the processing of ubiquitin precursors and of ubiquitinated proteins
  • may play an important regulatory role at the level of protein turnover by preventing degradation of proteins through the removal of conjugated ubiquitin
  • can stabilize MARCH7, and deubiquitylate MARCH7 in the cytosol
  • deubiquitinase acting as essential and evolutionarily conserved component in TGFbeta and bone morphogenetic protein signaling, opposing the activity of Ectodermin/Tif1gamma (Ecto, TRIM33)
  • enhances the polarity and self-renewal of embryonic stem cell-derived neural progenitors
  • stabilizes MCL1 and thereby promotes cell survival
  • controlling the level of PSD, mediating its deubuiquitination and protecting from proteasomal degradation, thus regulating de nov tight junction assembly
  • is an elongated monomeric protein with the capacity to hydrolyze thioester, isopeptide, and peptide bonds
  • implicated in the participation in the PEX5-mediated peroxisomal protein import pathway
  • acts as a negative regulator of MTOR activity and muscle differentiation
  • is a major tumour suppressor gene with prognostic and therapeutic relevance in pancreatic ductal adenocarcinoma
  • is a novel regulator of SMURF1 and is required for SMURF1-dependent cellular physiology
  • required for normal neuronal cell migration
  • substrate-specific deubiquitylating enzyme, and thus regulates the proteome
  • role in de-ubiquitination of ciliary proteins
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    TGFB pathway
    a component
  • component of the TGFB pathway
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • interacting with DCX to regulate cell adhesion
  • binding partner of ITCH (transient overexpression of FAM/USP9X resulted in the deubiquitylation of ITCH)
  • interacting with and deubiquitinating monoubiquitinated SMAD4, opposing the activity of Ectodermin/TIF1G (TRIM33), rather than stability
  • with TRIM33 act as antagonistic SMAD4 regulator during embryonic development
  • binding MCL1 and removing the Lys48-linked polyubiquitin chains
  • interacting with MCL1 (stabilizes MCL1 by reversing its polyubiquitination)
  • interacts with and deubiquitinates SNCA
  • involved in MCL1 protein turnover by preventing its degradation through the removal of conjugated ubiquitin
  • SMURF1 is known to bind the C terminus of USP9X and has established roles in cell migration
  • PMAIP1 over-expression caused a decrease in the USP9X/MCL1 interaction associated with an increase in the MCL1 polyubiquitinated forms
  • USP9X was found to be the most active deubiquitinase acting on ubiquitin-PEX5
  • novel MTOR and CRTC2 binding partner that negatively regulates MTOR activity and skeletal muscle differentiation
  • USP9X interacts with SMURF1 and stabilizes SMURF1 through deubiquitination
  • in B lymphocytes, USP9X is required for the induction of PRKCB activity after BCR-dependent activation
  • USP9X functions as a positive regulatory switch during T lymphocyte priming through removal of inhibitory monoubiquitination from ZAP70
  • USP9X is a novel regulator of the translation initiation process via deubiquitination of EIF4A1, which offers new insight in understanding the pivotal role of USP9X in malignancies and neurodevelopmental disorders
  • deubiquitinase, USP9X interacts with ZBTB38, deubiquitinates it, and stabilizes it
  • USP9X is a deubiquitinase of PBX1
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) MRX99 , MRXS99F
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    increased expression in follicular lymphomas and diffuse large B-cell lymphomas correlates with increased MCL1 expression and poor prognosis
    tumoral       loss of function
    inactivated in over 50p100 of the pancreatic ductal adenocarcinoma (PDA)
    constitutional     --low  
    lower levels of cytosolic USP9X and deubiquitinase activity in alpha-synucleinopathies may contribute to the accumulation and aggregation SNCA in Lewy bodies
    constitutional       loss of function
    resulted in changes to the neuronal cytoskeleton
    constitutional germinal mutation      
    associated with nonsyndromic X-linked intellectual disability
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
  • marker prognostic in follicular lymphomas and diffuse large B-cell lymphomas
  • Therapy target
    SystemTypeDisorderPubmed
    cancerreproductiveprostate
    targeting the USP9X/PBX1 axis could be a potential therapeutic strategy for managing advanced prostate cancer
    cancerhemopathy 
    therapy target in follicular lymphomas and diffuse large B-cell lymphomas
    ANIMAL & CELL MODELS